Dicer-DX: the first liquid biopsy for early detection and monitoring of DICER1 syndrome pediatric cancers

Ended Cooperative Agreement Awarded Last action

Award ID
R43CA228850
Recipient
Awarding agency
Obligated
$299,331

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date
Place of performance
Sterling, VA, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$183
Original award $299,514

Quick answers

Who received award R43CA228850?

R43CA228850 was awarded to Resourcepath, LLC by National Cancer Institute (National Institutes of Health) on May 7, 2018.

How much is award R43CA228850 worth?

$299,331 has been obligated on R43CA228850.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award